{"transactions":[{"id":3513291,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Warrant (right to buy)","published_at":"2026-09-08T20:05:55.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":false,"shares":784314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Warrant was immediately exercisable upon its acquisition on March 24, 2025, subject to the Issuer's right to call the Warrant at any time beginning 30 days following the release of the Issuer's OPGx-BEST1 DUO-1001 Cohort 1 data upon achievement of (i) a volume weighted average price of the Issuer's Common Stock for 30 consecutive trading days of over $1.725 per share and (ii) the trading average daily volume for such 30 day period exceeding $150,000 per trading day."}],"balance_after":0,"derivative":{"exercise_price":1.15,"expiration_date":"2030-03-25","underlying":"Common Stock","underlying_shares":784314},"source":{"system":"sec-edgar","filing":"0001140361-26-035913","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1557832/000114036126035913/form4.xml","form_type":"4"}},{"id":3513290,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-08T20:05:55.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":true,"shares":784314,"price":1.15,"value":901961.1,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In conjunction with the exercise of the Warrant reported herein, the Reporting Person entered into a Lock-Up Agreement with the Issuer dated September 6, 2026 (the \"Lock-Up Agreement\").  Pursuant to the Lock-Up Agreement, among other terms, the Reporting Person agreed that, without the prior written consent of the Issuer, during the period beginning on September 6, 2026 and ending at the close of business 180 days after the issuance of the shares of Common Stock underlying the Warrant, the Reporting Person will not transfer or dispose of, directly or indirectly, any shares of Common Stock, or any securities convertible into or exercisable or exchangeable for Common Stock (including, without limitation, Common Stock or such other securities which may be deemed to be beneficially owned by the Reporting Person and securities which may be issued upon exercise of a stock option or warrant), as further described in the Lock-Up Agreement and subject to certain exclusions described therein."}],"balance_after":2800111,"source":{"system":"sec-edgar","filing":"0001140361-26-035913","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557832/000114036126035913/form4.xml","form_type":"4"}},{"id":802609,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T20:30:42.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":24367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":2015797,"source":{"system":"sec-edgar","filing":"0000905148-26-001785","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826001785/form4.xml","form_type":"4"}},{"id":943112,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-08T21:13:05.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest on December 29, 2026, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":1991430,"source":{"system":"sec-edgar","filing":"0000905148-26-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826000088/form4.xml","form_type":"4"}},{"id":956412,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-31T21:33:33.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents a grant of restricted stock units (\"RSUs\") which vest on December 29, 2026, subject to the Reporting Person's continuing service through the vesting date."},{"field":"shares","element":"transactionShares","label":"F5","text":"On December 31, 2025, the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 6, 2026, of an additional 67,000 RSUs which vest on December 29, 2026, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":1924430,"source":{"system":"sec-edgar","filing":"0000905148-25-004511","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825004511/form4.xml","form_type":"4"}},{"id":956411,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-31T21:33:33.000Z","date":"2025-12-29","kind":"purchase","planned":false,"acquired":true,"shares":83000,"price":1.9689,"value":163418.7,"ownership":{"direct":false,"nature":"By Garret Gallagher - Custodian UTMA/UGMA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.9476 to $1.98, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":83000,"source":{"system":"sec-edgar","filing":"0000905148-25-004511","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825004511/form4.xml","form_type":"4"}},{"id":956410,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-31T21:33:33.000Z","date":"2025-12-29","kind":"purchase","planned":false,"acquired":true,"shares":81000,"price":1.9787,"value":160274.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.945 to $1.98, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":1891430,"source":{"system":"sec-edgar","filing":"0000905148-25-004511","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825004511/form4.xml","form_type":"4"}},{"id":1054415,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-27T20:15:19.000Z","date":"2025-08-25","kind":"grant","planned":false,"acquired":true,"shares":869565,"price":1.15,"value":999999.75,"ownership":{"direct":true},"balance_after":1810430,"source":{"system":"sec-edgar","filing":"0000905148-25-003152","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825003152/form4.xml","form_type":"4"}},{"id":1160921,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-02T21:05:38.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":79592,"derivative":{"exercise_price":0.95,"expiration_date":"2035-04-29","underlying":"Common Stock","underlying_shares":79592},"source":{"system":"sec-edgar","filing":"0000905148-25-001427","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001427/form4.xml","form_type":"4"}},{"id":1160920,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-02T21:05:38.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":940865,"source":{"system":"sec-edgar","filing":"0000905148-25-001427","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001427/form4.xml","form_type":"4"}},{"id":1190740,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Warrants (right to buy)","published_at":"2025-03-26T20:08:12.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":784314,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These warrants are immediately exercisable and may be called by the Issuer at any time starting with 30 days following the release of the Issuer's OPGx-BEST1 DUO-1001 Cohort 1 data upon achievement of (i) a volume weighted average price of the Issuer's common stock for 30 consecutive trading days of over $1.725 per share and (ii) the trading average daily volume for such 30 day period exceeding $150,000 per trading day."}],"balance_after":784314,"derivative":{"exercise_price":1.15,"expiration_date":"2030-03-24","underlying":"Common Stock","underlying_shares":784314},"source":{"system":"sec-edgar","filing":"0000905148-25-001006","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001006/form4.xml","form_type":"4"}},{"id":1190739,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-26T20:08:12.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":784314,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275."}],"balance_after":861361,"source":{"system":"sec-edgar","filing":"0000905148-25-001006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001006/form4.xml","form_type":"4"}},{"id":1480381,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T21:27:33.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":35181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":35181,"derivative":{"exercise_price":1.72,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":35181},"source":{"system":"sec-edgar","filing":"0000905148-24-001711","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514824001711/form4.xml","form_type":"4"}},{"id":1480380,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-13T21:27:33.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":41143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":77047,"source":{"system":"sec-edgar","filing":"0000905148-24-001711","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514824001711/form4.xml","form_type":"4"}},{"id":1496731,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Interim CFO"}}],"security":"Common Stock","published_at":"2024-05-31T22:27:15.000Z","date":"2024-05-31","kind":"sale","planned":false,"acquired":false,"shares":9597,"price":11.98,"value":114972.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person."}],"balance_after":633680,"source":{"system":"sec-edgar","filing":"0001725160-24-000127","document":"wk-form4_1717194425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516024000127/wk-form4_1717194425.xml","form_type":"4"}},{"id":1649372,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2024-02-13T01:21:42.000Z","date":"2024-02-12","kind":"sale","planned":false,"acquired":false,"shares":1173,"price":11.44,"value":13419.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $11.29 to $11.56. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":643277,"source":{"system":"sec-edgar","filing":"0001725160-24-000041","document":"wk-form4_1707787292.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516024000041/wk-form4_1707787292.xml","form_type":"4"}},{"id":1658980,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-06T00:13:51.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":192500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest over four years in equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":192500,"derivative":{"exercise_price":11.69,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":192500},"source":{"system":"sec-edgar","filing":"0001725160-24-000030","document":"wk-form4_1707178402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516024000030/wk-form4_1707178402.xml","form_type":"4"}},{"id":1658979,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2024-02-06T00:13:51.000Z","date":"2024-02-02","kind":"sale","planned":false,"acquired":false,"shares":11552,"price":11.54,"value":133310.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $11.35 to $11.64. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":644450,"source":{"system":"sec-edgar","filing":"0001725160-24-000030","document":"wk-form4_1707178402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516024000030/wk-form4_1707178402.xml","form_type":"4"}},{"id":1658978,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2024-02-06T00:13:51.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":192500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":656002,"source":{"system":"sec-edgar","filing":"0001725160-24-000030","document":"wk-form4_1707178402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516024000030/wk-form4_1707178402.xml","form_type":"4"}},{"id":1861998,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Stock Option","published_at":"2023-06-08T22:48:56.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":9639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":9639,"derivative":{"exercise_price":3.83,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":9639},"source":{"system":"sec-edgar","filing":"0001140361-23-029020","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036123029020/form4.xml","form_type":"4"}},{"id":1861997,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-08T22:48:56.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":10976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":35904,"source":{"system":"sec-edgar","filing":"0001140361-23-029020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036123029020/form4.xml","form_type":"4"}},{"id":1873376,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-06-01T01:10:35.000Z","date":"2023-05-31","kind":"sale","planned":true,"acquired":false,"shares":18526,"price":26.2079,"value":485527.5554,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $25.91 to $26.51. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":463502,"source":{"system":"sec-edgar","filing":"0001725160-23-000125","document":"wk-form4_1685581824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000125/wk-form4_1685581824.xml","form_type":"4"}},{"id":1873375,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-06-01T01:10:35.000Z","date":"2023-05-31","kind":"sale","planned":true,"acquired":false,"shares":9242,"price":26.3989,"value":243978.6338,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."}],"balance_after":482028,"source":{"system":"sec-edgar","filing":"0001725160-23-000125","document":"wk-form4_1685581824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000125/wk-form4_1685581824.xml","form_type":"4"}},{"id":2016550,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-02-15T00:09:28.000Z","date":"2023-02-14","kind":"sale","acquired":false,"shares":8501,"price":19.9631,"value":169706.3131,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $19.73 to $20.30. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":491270,"source":{"system":"sec-edgar","filing":"0001725160-23-000033","document":"wf-form4_167641974905249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000033/wf-form4_167641974905249.xml","form_type":"4"}},{"id":2016549,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-02-15T00:09:28.000Z","date":"2023-02-13","kind":"sale","acquired":false,"shares":3332,"price":20.4244,"value":68054.1008,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $19.79 to $20.64. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":499771,"source":{"system":"sec-edgar","filing":"0001725160-23-000033","document":"wf-form4_167641974905249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000033/wf-form4_167641974905249.xml","form_type":"4"}},{"id":2030644,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-02-07T00:36:13.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":572,"price":23.0351,"value":13176.0772,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $22.88 to $23.12. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":503103,"source":{"system":"sec-edgar","filing":"0001725160-23-000022","document":"wf-form4_167573016060449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000022/wf-form4_167573016060449.xml","form_type":"4"}},{"id":2030643,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-02-07T00:36:13.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":9428,"price":22.2213,"value":209502.4164,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $21.77 to $22.76. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":503675,"source":{"system":"sec-edgar","filing":"0001725160-23-000022","document":"wf-form4_167573016060449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000022/wf-form4_167573016060449.xml","form_type":"4"}},{"id":2038584,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T00:08:40.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":233908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date."}],"balance_after":233908,"derivative":{"exercise_price":23.65,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":233908},"source":{"system":"sec-edgar","filing":"0001725160-23-000019","document":"wf-form4_167529650576789.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000019/wf-form4_167529650576789.xml","form_type":"4"}},{"id":2038583,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-02-02T00:08:40.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":161092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date."}],"balance_after":513103,"source":{"system":"sec-edgar","filing":"0001725160-23-000019","document":"wf-form4_167529650576789.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000019/wf-form4_167529650576789.xml","form_type":"4"}},{"id":2052491,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-01-18T22:15:03.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":500,"price":24.8672,"value":12433.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $24.78 to $24.93. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":352011,"source":{"system":"sec-edgar","filing":"0001725160-23-000008","document":"wf-form4_167408008586817.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000008/wf-form4_167408008586817.xml","form_type":"4"}},{"id":2052490,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-01-18T22:15:03.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":9500,"price":24.1138,"value":229081.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $23.76 to $24.75. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":352511,"source":{"system":"sec-edgar","filing":"0001725160-23-000008","document":"wf-form4_167408008586817.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000008/wf-form4_167408008586817.xml","form_type":"4"}},{"id":2060168,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Series B Warrant (right to buy)","published_at":"2023-01-06T14:00:21.000Z","date":"2023-01-04","kind":"other","acquired":false,"shares":1574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The expiration date of the Series B Warrants occurred on the later of (x) the Reservation Date (as defined in the Series B Warrants) and (y) the date on which the Series B Warrants has been exercised in full."}],"balance_after":0,"derivative":{"exercise_price":0.0001,"exercise_date":"2020-11-19","expiration_date":"2023-01-05","underlying":"Common Stock","underlying_shares":1574},"source":{"system":"sec-edgar","filing":"0001140361-23-000746","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036123000746/form4.xml","form_type":"4"}},{"id":2060167,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-06T14:00:21.000Z","date":"2023-01-04","kind":"other","acquired":true,"shares":1574,"price":0.0001,"value":0.1574,"ownership":{"direct":true},"balance_after":24928,"source":{"system":"sec-edgar","filing":"0001140361-23-000746","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036123000746/form4.xml","form_type":"4"}},{"id":2062848,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-01-06T00:16:31.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":300,"price":21.4567,"value":6437.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $21.44 to $21.47. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":362011,"source":{"system":"sec-edgar","filing":"0001725160-23-000002","document":"wf-form4_167296417221057.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000002/wf-form4_167296417221057.xml","form_type":"4"}},{"id":2062847,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-01-06T00:16:31.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":9700,"price":21.0094,"value":203791.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $20.39 to $21.35. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":362311,"source":{"system":"sec-edgar","filing":"0001725160-23-000002","document":"wf-form4_167296417221057.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000002/wf-form4_167296417221057.xml","form_type":"4"}},{"id":2116228,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-11-16T00:50:44.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":900,"price":23.479,"value":21131.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $23.21 to $23.57. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":372011,"source":{"system":"sec-edgar","filing":"0001725160-22-000202","document":"wf-form4_166855982730331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000202/wf-form4_166855982730331.xml","form_type":"4"}},{"id":2116227,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-11-16T00:50:44.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":11600,"price":22.72,"value":263552.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $22.20 to $23.17. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":372911,"source":{"system":"sec-edgar","filing":"0001725160-22-000202","document":"wf-form4_166855982730331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000202/wf-form4_166855982730331.xml","form_type":"4"}},{"id":2122334,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-11-09T01:38:59.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":12374,"price":23.5609,"value":291542.5766,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $23.18 to $23.94. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":384511,"source":{"system":"sec-edgar","filing":"0001725160-22-000194","document":"wf-form4_166795791845543.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000194/wf-form4_166795791845543.xml","form_type":"4"}},{"id":2122333,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-11-09T01:38:59.000Z","date":"2022-11-07","kind":"sale","acquired":false,"shares":157,"price":24.2374,"value":3805.2718,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $24.22 to $24.31. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":396885,"source":{"system":"sec-edgar","filing":"0001725160-22-000194","document":"wf-form4_166795791845543.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000194/wf-form4_166795791845543.xml","form_type":"4"}},{"id":2122332,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-11-09T01:38:59.000Z","date":"2022-11-07","kind":"sale","acquired":false,"shares":12343,"price":23.6616,"value":292055.1288,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $23.16 to $24.11. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":397042,"source":{"system":"sec-edgar","filing":"0001725160-22-000194","document":"wf-form4_166795791845543.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000194/wf-form4_166795791845543.xml","form_type":"4"}},{"id":2136373,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-10-18T01:02:14.000Z","date":"2022-10-17","kind":"sale","acquired":false,"shares":12500,"price":23.5103,"value":293878.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $23.00 to $23.96. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":409385,"source":{"system":"sec-edgar","filing":"0001725160-22-000184","document":"wf-form4_166605490632481.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000184/wf-form4_166605490632481.xml","form_type":"4"}},{"id":2140485,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-10-07T20:40:26.000Z","date":"2022-10-06","kind":"sale","acquired":false,"shares":10000,"price":22.618,"value":226180.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $22.20 to $23.11. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":421885,"source":{"system":"sec-edgar","filing":"0001725160-22-000182","document":"wf-form4_166517520562805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000182/wf-form4_166517520562805.xml","form_type":"4"}},{"id":2140484,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-10-07T20:40:26.000Z","date":"2022-10-05","kind":"sale","acquired":false,"shares":5496,"price":22.8308,"value":125478.0768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $22.47 to $23.17. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":431885,"source":{"system":"sec-edgar","filing":"0001725160-22-000182","document":"wf-form4_166517520562805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000182/wf-form4_166517520562805.xml","form_type":"4"}},{"id":2140483,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-10-07T20:40:26.000Z","date":"2022-10-05","kind":"sale","acquired":false,"shares":7004,"price":21.9201,"value":153528.3804,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $21.43 to $22.42. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":437381,"source":{"system":"sec-edgar","filing":"0001725160-22-000182","document":"wf-form4_166517520562805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000182/wf-form4_166517520562805.xml","form_type":"4"}},{"id":2157408,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-09-17T00:25:46.000Z","date":"2022-09-16","kind":"sale","acquired":false,"shares":1134,"price":24.9898,"value":28338.4332,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $24.84 to $25.12. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":444385,"source":{"system":"sec-edgar","filing":"0001725160-22-000167","document":"wf-form4_166337433049948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000167/wf-form4_166337433049948.xml","form_type":"4"}},{"id":2157407,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-09-17T00:25:46.000Z","date":"2022-09-16","kind":"sale","acquired":false,"shares":8866,"price":24.3806,"value":216158.3996,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $23.83 to $24.78. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":445519,"source":{"system":"sec-edgar","filing":"0001725160-22-000167","document":"wf-form4_166337433049948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000167/wf-form4_166337433049948.xml","form_type":"4"}},{"id":2157406,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-09-17T00:25:46.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":4074,"price":25.5866,"value":104239.8084,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $25.39 to $25.95. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":454385,"source":{"system":"sec-edgar","filing":"0001725160-22-000167","document":"wf-form4_166337433049948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000167/wf-form4_166337433049948.xml","form_type":"4"}},{"id":2157405,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-09-17T00:25:46.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":8426,"price":25.1029,"value":211517.0354,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $24.39 to $25.38. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":458459,"source":{"system":"sec-edgar","filing":"0001725160-22-000167","document":"wf-form4_166337433049948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000167/wf-form4_166337433049948.xml","form_type":"4"}},{"id":2231286,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-06-15T20:01:43.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":1.93,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-22-023051","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036122023051/form4.xml","form_type":"4"}},{"id":2251494,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-31T20:06:08.000Z","date":"2022-05-30","kind":"grant","acquired":true,"shares":333218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable as to 25% of the total number of shares underlying the option on May 30, 2023 and as to the remaining 75% in 36 substantially equal monthly installments thereafter."}],"balance_after":333218,"derivative":{"exercise_price":24.75,"expiration_date":"2032-05-29","underlying":"Common Stock","underlying_shares":333218},"source":{"system":"sec-edgar","filing":"0001725160-22-000116","document":"wf-form4_165402754252137.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000116/wf-form4_165402754252137.xml","form_type":"4"}},{"id":2251493,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-05-31T20:06:08.000Z","date":"2022-05-30","kind":"grant","acquired":true,"shares":111072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date."}],"balance_after":466885,"source":{"system":"sec-edgar","filing":"0001725160-22-000116","document":"wf-form4_165402754252137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000116/wf-form4_165402754252137.xml","form_type":"4"}},{"id":2304634,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T22:52:36.000Z","date":"2022-04-05","kind":"sale","acquired":false,"shares":100,"price":52.7,"value":5270.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."}],"balance_after":355813,"source":{"system":"sec-edgar","filing":"0001725160-22-000067","document":"wf-form4_164919913574721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000067/wf-form4_164919913574721.xml","form_type":"4"}},{"id":2304633,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T22:52:36.000Z","date":"2022-04-05","kind":"sale","acquired":false,"shares":2196,"price":51.5861,"value":113283.0756,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $51.21 to $52.07. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":355913,"source":{"system":"sec-edgar","filing":"0001725160-22-000067","document":"wf-form4_164919913574721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000067/wf-form4_164919913574721.xml","form_type":"4"}},{"id":2304632,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T22:52:36.000Z","date":"2022-04-05","kind":"sale","acquired":false,"shares":3335,"price":50.6775,"value":169009.4625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $50.20 to $51.18. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":358109,"source":{"system":"sec-edgar","filing":"0001725160-22-000067","document":"wf-form4_164919913574721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000067/wf-form4_164919913574721.xml","form_type":"4"}},{"id":2304631,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T22:52:36.000Z","date":"2022-04-05","kind":"sale","acquired":false,"shares":4369,"price":49.7153,"value":217206.1457,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.20 to $50.18. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":361444,"source":{"system":"sec-edgar","filing":"0001725160-22-000067","document":"wf-form4_164919913574721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000067/wf-form4_164919913574721.xml","form_type":"4"}},{"id":2330844,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-16T21:18:11.000Z","date":"2022-03-15","kind":"sale","acquired":false,"shares":100,"price":43.18,"value":4318.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."}],"balance_after":365813,"source":{"system":"sec-edgar","filing":"0001725160-22-000061","document":"wf-form4_164746547616410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000061/wf-form4_164746547616410.xml","form_type":"4"}},{"id":2330843,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-16T21:18:11.000Z","date":"2022-03-15","kind":"sale","acquired":false,"shares":5322,"price":42.3107,"value":225177.5454,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $41.78 to $42.755. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":365913,"source":{"system":"sec-edgar","filing":"0001725160-22-000061","document":"wf-form4_164746547616410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000061/wf-form4_164746547616410.xml","form_type":"4"}},{"id":2330842,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-16T21:18:11.000Z","date":"2022-03-15","kind":"sale","acquired":false,"shares":4578,"price":41.4473,"value":189745.7394,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $40.78 to $41.77. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":371235,"source":{"system":"sec-edgar","filing":"0001725160-22-000061","document":"wf-form4_164746547616410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000061/wf-form4_164746547616410.xml","form_type":"4"}},{"id":2344686,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-09T00:43:28.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":523,"price":45.5607,"value":23828.2461,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $45.55 to $45.75. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":375813,"source":{"system":"sec-edgar","filing":"0001725160-22-000057","document":"wf-form4_164678659275401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000057/wf-form4_164678659275401.xml","form_type":"4"}},{"id":2344685,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-09T00:43:28.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":9477,"price":44.9044,"value":425558.9988,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $44.34 to $45.33. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":376336,"source":{"system":"sec-edgar","filing":"0001725160-22-000057","document":"wf-form4_164678659275401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000057/wf-form4_164678659275401.xml","form_type":"4"}},{"id":2394620,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-15T23:35:16.000Z","date":"2022-02-15","kind":"sale","acquired":false,"shares":1370,"price":52.737,"value":72249.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $52.61 to $53.18. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":385813,"source":{"system":"sec-edgar","filing":"0001725160-22-000038","document":"wf-form4_164496810181700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000038/wf-form4_164496810181700.xml","form_type":"4"}},{"id":2394619,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-15T23:35:16.000Z","date":"2022-02-15","kind":"sale","acquired":false,"shares":5366,"price":52.1529,"value":279852.4614,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $51.60 to $52.59. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":387183,"source":{"system":"sec-edgar","filing":"0001725160-22-000038","document":"wf-form4_164496810181700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000038/wf-form4_164496810181700.xml","form_type":"4"}},{"id":2394618,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-15T23:35:16.000Z","date":"2022-02-15","kind":"sale","acquired":false,"shares":3264,"price":51.2232,"value":167192.5248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $50.59 to $51.57. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":392549,"source":{"system":"sec-edgar","filing":"0001725160-22-000038","document":"wf-form4_164496810181700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000038/wf-form4_164496810181700.xml","form_type":"4"}},{"id":2398179,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T02:09:19.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":19245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date."}],"balance_after":19245,"derivative":{"exercise_price":52.61,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":19245},"source":{"system":"sec-edgar","filing":"0001725160-22-000032","document":"wf-form4_164489091255122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000032/wf-form4_164489091255122.xml","form_type":"4"}},{"id":2398178,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-15T02:09:19.000Z","date":"2022-02-14","kind":"sale","acquired":false,"shares":4850,"price":50.1732,"value":243340.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.77 to $50.67. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":395813,"source":{"system":"sec-edgar","filing":"0001725160-22-000032","document":"wf-form4_164489091255122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000032/wf-form4_164489091255122.xml","form_type":"4"}},{"id":2398177,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-15T02:09:19.000Z","date":"2022-02-14","kind":"sale","acquired":false,"shares":259,"price":50.7472,"value":13143.5248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $50.58 to $50.81. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":400663,"source":{"system":"sec-edgar","filing":"0001725160-22-000032","document":"wf-form4_164489091255122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000032/wf-form4_164489091255122.xml","form_type":"4"}},{"id":2398176,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-15T02:09:19.000Z","date":"2022-02-14","kind":"sale","acquired":false,"shares":2079,"price":50.1642,"value":104291.3718,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.58 to $50.56. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":400922,"source":{"system":"sec-edgar","filing":"0001725160-22-000032","document":"wf-form4_164489091255122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000032/wf-form4_164489091255122.xml","form_type":"4"}},{"id":2398175,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-15T02:09:19.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":7595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in full on the first anniversary of the grant date."}],"balance_after":403001,"source":{"system":"sec-edgar","filing":"0001725160-22-000032","document":"wf-form4_164489091255122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000032/wf-form4_164489091255122.xml","form_type":"4"}},{"id":2398174,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-15T02:09:19.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":8203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date."}],"balance_after":395406,"source":{"system":"sec-edgar","filing":"0001725160-22-000032","document":"wf-form4_164489091255122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000032/wf-form4_164489091255122.xml","form_type":"4"}},{"id":2410162,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-08T02:53:18.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":1250,"price":54.3524,"value":67940.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $54.20 to $54.50. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":387203,"source":{"system":"sec-edgar","filing":"0001725160-22-000019","document":"wf-form4_164428878233215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000019/wf-form4_164428878233215.xml","form_type":"4"}},{"id":2410161,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-08T02:53:18.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":6460,"price":53.5118,"value":345686.228,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $53.03 to $54.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":388453,"source":{"system":"sec-edgar","filing":"0001725160-22-000019","document":"wf-form4_164428878233215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000019/wf-form4_164428878233215.xml","form_type":"4"}},{"id":2410160,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-08T02:53:18.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":2290,"price":52.7717,"value":120847.193,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $52.02 to $52.97. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":394913,"source":{"system":"sec-edgar","filing":"0001725160-22-000019","document":"wf-form4_164428878233215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000019/wf-form4_164428878233215.xml","form_type":"4"}},{"id":2432369,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-20T00:21:37.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":1300,"price":64.6631,"value":84062.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $64.23 to $65.19. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":397203,"source":{"system":"sec-edgar","filing":"0001725160-22-000011","document":"wf-form4_164263808105131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000011/wf-form4_164263808105131.xml","form_type":"4"}},{"id":2432368,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-20T00:21:37.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":1842,"price":63.4466,"value":116868.6372,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $63.09 to $63.92. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":398503,"source":{"system":"sec-edgar","filing":"0001725160-22-000011","document":"wf-form4_164263808105131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000011/wf-form4_164263808105131.xml","form_type":"4"}},{"id":2432367,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-20T00:21:37.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":3424,"price":62.367,"value":213544.608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $62.01 to $62.93. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":400345,"source":{"system":"sec-edgar","filing":"0001725160-22-000011","document":"wf-form4_164263808105131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000011/wf-form4_164263808105131.xml","form_type":"4"}},{"id":2432366,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-20T00:21:37.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":3434,"price":61.7066,"value":211900.4644,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $61.01 to $62.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":403769,"source":{"system":"sec-edgar","filing":"0001725160-22-000011","document":"wf-form4_164263808105131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000011/wf-form4_164263808105131.xml","form_type":"4"}},{"id":2444131,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T22:49:10.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":100,"price":78.91,"value":7891.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."}],"balance_after":407203,"source":{"system":"sec-edgar","filing":"0001725160-22-000004","document":"wf-form4_164142291575887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000004/wf-form4_164142291575887.xml","form_type":"4"}},{"id":2444130,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T22:49:10.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":1156,"price":78.2444,"value":90450.5264,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $77.76 to $78.70. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":407303,"source":{"system":"sec-edgar","filing":"0001725160-22-000004","document":"wf-form4_164142291575887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000004/wf-form4_164142291575887.xml","form_type":"4"}},{"id":2444129,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T22:49:10.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":1106,"price":76.9026,"value":85054.2756,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $76.68 to $77.31. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":408459,"source":{"system":"sec-edgar","filing":"0001725160-22-000004","document":"wf-form4_164142291575887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000004/wf-form4_164142291575887.xml","form_type":"4"}},{"id":2444128,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T22:49:10.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":3641,"price":76.0255,"value":276808.8455,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $75.62 to $76.60. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":409565,"source":{"system":"sec-edgar","filing":"0001725160-22-000004","document":"wf-form4_164142291575887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000004/wf-form4_164142291575887.xml","form_type":"4"}},{"id":2444127,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T22:49:10.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":700,"price":75.3214,"value":52724.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $74.61 to $75.60. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":413206,"source":{"system":"sec-edgar","filing":"0001725160-22-000004","document":"wf-form4_164142291575887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000004/wf-form4_164142291575887.xml","form_type":"4"}},{"id":2444126,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T22:49:10.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":900,"price":73.9156,"value":66524.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $73.61 to $74.51. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":413906,"source":{"system":"sec-edgar","filing":"0001725160-22-000004","document":"wf-form4_164142291575887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000004/wf-form4_164142291575887.xml","form_type":"4"}},{"id":2444125,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T22:49:10.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":2397,"price":73.1779,"value":175407.4263,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $72.59 to $73.53. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":414806,"source":{"system":"sec-edgar","filing":"0001725160-22-000004","document":"wf-form4_164142291575887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000004/wf-form4_164142291575887.xml","form_type":"4"}},{"id":2469965,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T22:18:34.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":527,"price":78.9651,"value":41614.6077,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $78.81 to $79.25. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":417203,"source":{"system":"sec-edgar","filing":"0001725160-21-000240","document":"wf-form4_163969309168141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000240/wf-form4_163969309168141.xml","form_type":"4"}},{"id":2469964,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T22:18:34.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":1524,"price":78.2139,"value":119197.9836,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $77.81 to $78.80. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":417730,"source":{"system":"sec-edgar","filing":"0001725160-21-000240","document":"wf-form4_163969309168141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000240/wf-form4_163969309168141.xml","form_type":"4"}},{"id":2469963,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T22:18:34.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":520,"price":77.2438,"value":40166.776,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $76.78 to $77.73. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":419254,"source":{"system":"sec-edgar","filing":"0001725160-21-000240","document":"wf-form4_163969309168141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000240/wf-form4_163969309168141.xml","form_type":"4"}},{"id":2469962,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T22:18:34.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":311,"price":76.0656,"value":23656.4016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $75.49 to $76.41. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":419774,"source":{"system":"sec-edgar","filing":"0001725160-21-000240","document":"wf-form4_163969309168141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000240/wf-form4_163969309168141.xml","form_type":"4"}},{"id":2469961,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T22:18:34.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":1117,"price":74.4972,"value":83213.3724,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $73.95 to $74.81. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":420085,"source":{"system":"sec-edgar","filing":"0001725160-21-000240","document":"wf-form4_163969309168141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000240/wf-form4_163969309168141.xml","form_type":"4"}},{"id":2469960,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T22:18:34.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":1900,"price":73.3489,"value":139362.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $72.92 to $73.85. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":421202,"source":{"system":"sec-edgar","filing":"0001725160-21-000240","document":"wf-form4_163969309168141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000240/wf-form4_163969309168141.xml","form_type":"4"}},{"id":2469959,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T22:18:34.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":1100,"price":72.0091,"value":79210.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $71.69 to $72.49. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":423102,"source":{"system":"sec-edgar","filing":"0001725160-21-000240","document":"wf-form4_163969309168141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000240/wf-form4_163969309168141.xml","form_type":"4"}},{"id":2469958,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T22:18:34.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":3001,"price":71.2811,"value":213914.5811,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $70.69 to $71.67. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":424202,"source":{"system":"sec-edgar","filing":"0001725160-21-000240","document":"wf-form4_163969309168141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000240/wf-form4_163969309168141.xml","form_type":"4"}},{"id":2482343,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-08T01:35:25.000Z","date":"2021-12-06","kind":"sale","acquired":false,"shares":10000,"price":71.33,"value":713300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."}],"balance_after":427203,"source":{"system":"sec-edgar","filing":"0001725160-21-000235","document":"wf-form4_163892730874818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000235/wf-form4_163892730874818.xml","form_type":"4"}},{"id":2510742,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-17T00:11:08.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":986,"price":76.6673,"value":75593.9578,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $76.49 to $77.17. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":437203,"source":{"system":"sec-edgar","filing":"0001725160-21-000224","document":"wf-form4_163710784629841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000224/wf-form4_163710784629841.xml","form_type":"4"}},{"id":2510741,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-17T00:11:08.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":2400,"price":75.7637,"value":181832.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $75.48 to $76.42. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":438189,"source":{"system":"sec-edgar","filing":"0001725160-21-000224","document":"wf-form4_163710784629841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000224/wf-form4_163710784629841.xml","form_type":"4"}},{"id":2510740,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-17T00:11:08.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":6614,"price":75.0215,"value":496192.201,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $74.47 to $75.46. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":440589,"source":{"system":"sec-edgar","filing":"0001725160-21-000224","document":"wf-form4_163710784629841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000224/wf-form4_163710784629841.xml","form_type":"4"}},{"id":2522995,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-06T01:12:42.000Z","date":"2021-11-05","kind":"sale","acquired":false,"shares":2400,"price":83.786,"value":201086.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $83.54 to $83.99. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":447203,"source":{"system":"sec-edgar","filing":"0001725160-21-000213","document":"wf-form4_163616114738577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000213/wf-form4_163616114738577.xml","form_type":"4"}},{"id":2522994,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-06T01:12:42.000Z","date":"2021-11-05","kind":"sale","acquired":false,"shares":5094,"price":82.9758,"value":422678.7252,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $82.51 to $83.50. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":449603,"source":{"system":"sec-edgar","filing":"0001725160-21-000213","document":"wf-form4_163616114738577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000213/wf-form4_163616114738577.xml","form_type":"4"}},{"id":2522993,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-06T01:12:42.000Z","date":"2021-11-05","kind":"sale","acquired":false,"shares":2506,"price":82.0933,"value":205725.8098,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $81.47 to $82.43. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":454697,"source":{"system":"sec-edgar","filing":"0001725160-21-000213","document":"wf-form4_163616114738577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000213/wf-form4_163616114738577.xml","form_type":"4"}},{"id":2552162,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T01:17:24.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":616,"price":67.3724,"value":41501.3984,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $67.18 to $67.56. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":457203,"source":{"system":"sec-edgar","filing":"0001725160-21-000201","document":"wf-form4_163339662219017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000201/wf-form4_163339662219017.xml","form_type":"4"}},{"id":2552161,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T01:17:24.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":4820,"price":66.7697,"value":321829.954,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $66.18 to $67.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":457819,"source":{"system":"sec-edgar","filing":"0001725160-21-000201","document":"wf-form4_163339662219017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000201/wf-form4_163339662219017.xml","form_type":"4"}}],"next_cursor":"2021-10-05T01:17:24.000000Z,2552161"}